Top compounds associated with response to PELI3


Feature Type Standardized
Nominal ANOVA
mRNA prima-1 CTRPv2 pan-cancer AAC 0.081 0.01
mRNA BMS-270394 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.097 0.01
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.01
mRNA GSK690693 GDSC1000 pan-cancer AAC 0.077 0.01
mRNA Salubrinal GDSC1000 pan-cancer AAC 0.13 0.01
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.01
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.07 0.01
mRNA GSK2126458 GDSC1000 pan-cancer AAC 0.075 0.01
mRNA Topotecan CCLE pan-cancer AAC -0.11 0.01
Download CSV